Skip to main content

(Z)-7-(2-(2-AMINOTHIAZOL-4-YL)-2-METHOXYIMINOACETAMIDO)-3-(5-CARBOXYMETHYL-4-METHYLTHIAZOL-2-YLTHIOMETHYL)-3-CEPHEM-4-CARBOXYLIC ACID, DISODIUM SALT

Chemical FDA Substance Registry (openFDA)
Chemical Identification
CAS Number86329-79-5
INCI Namedisodium;(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[[5-(carboxylatomethyl)-4-methyl-1,3-thiazol-2-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
PubChem CID 9852176
Molecular FormulaC20H18N6Na2O7S4
InChIKeyInChI=1S/C20H20N6O7S4.2Na/c
SMILESCC1=C(SC(=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-])CC(=O)[O-].[Na+].[Na+]
Known Aliases (17)
Common Name
5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-(((2-AMINO-4-THIAZOLYL)(METHOXYIMINO)ACETYL)AMINO)-3-(((5-(CARBOXYMETHYL)-4-METHYL-2-THIAZOLYL)THIO)METHYL)-8-OXO-, DISODIUM SALT, (6R-(6.ALPHA.,7.BETA.(Z)))- 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-(((2Z)-(2-AMINO-4-THIAZOLYL)(METHOXYIMINO)ACETYL)AMINO)-3-(((5-(CARBOXYMETHYL)-4-METHYL-2-THIAZOLYL)THIO)METHYL)-8-OXO-, DISODIUM SALT, (6R,7R)- 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-(((2Z)-(2-AMINO-4-THIAZOLYL)(METHOXYIMINO)ACETYL)AMINO)-3-(((5-(CARBOXYMETHYL)-4-METHYL-2-THIAZOLYL)THIO)METHYL)-8-OXO-, SODIUM SALT (1:2), (6R,7R)- CEFODIZIME DISODIUM CEFODIZIME DISODIUM SALT CEFODIZIME DISODIUM SALT [MI] Cefodizime disodium [WHO-DD] CEFODIZIME SODIUM CEFODIZIME SODIUM [MART.] HR 221 HR-221 S 77 1221 B S 77-1221B S-77-1221-B S-77-1221B THR 221 THR-221
Data Sources (1)
Source Source ID Name in Source Properties
FDA Substance Registry (openFDA) HC1T51593A (Z)-7-(2-(2-AMINOTHIAZOL-4-YL)-2-METHOXYIMINOACETAMIDO)-3-(5-CARBOXYMETHYL-4-METHYLTHIAZOL-2-YLTHIOMETHYL)-3-CEPHEM-4-CARBOXYLIC ACID, DISODIUM SALT CAS: 86329-79-5
EVMPD: SUB01120MIG
ChEMBL: CHEMBL2303613
SMS_ID: 100000084698
PUBCHEM: 9852176
FDA UNII: HC1T51593A
DRUG BANK: DBSALT002923
EPA CompTox: DTXSID9046730
MERCK INDEX: m3199
NCI_THESAURUS: C357
Record Info
IDeLVygpQhvYwrNGHdALSG2b
CreatedApril 10, 2026, 8:47 p.m.
ModifiedApril 10, 2026, 11:37 p.m.
EnrichedApril 11, 2026, 12:09 a.m.
Data SourceFDA Substance Registry (openFDA)